Proton-Pump Inhibitors and Cardiovascular Risk (vol 153, pg 378, 2010)

被引：1
|
作者：
Charlot
机构：
来源：
ANNALS OF INTERNAL MEDICINE | 2011年 / 154卷 / 01期
关键词：
D O I：
10.7326/0003-4819-154-1-201101040-00020
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：76 / 76
页数：1
相关论文
共 50 条
  • [21] Proton-pump inhibitors and hypomagnesemic hypoparathyroidism
    Epstein, Martin
    McGrath, Shaun
    Law, Florence
    NEW ENGLAND JOURNAL OF MEDICINE, 2006, 355 (17): : 1834 - 1836
  • [22] Tetany, Hypomagnesemia, and Proton-pump Inhibitors
    Famularo, Giuseppe
    Minisola, Giovanni
    Bravi, Maria Cristina
    Colucci, Pasquale
    Gasbarrone, Laura
    AMERICAN JOURNAL OF MEDICINE, 2012, 125 (10): : E7 - E8
  • [23] Anaphylactic reactions to proton-pump inhibitors
    Natsch, S
    Vinks, MHAM
    Voogt, AK
    Mees, EB
    Meyboom, RHB
    ANNALS OF PHARMACOTHERAPY, 2000, 34 (04) : 474 - 476
  • [24] Proton-pump inhibitors in managed care
    Frear, RS
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1998, 55 (21) : 2249 - 2249
  • [25] Heartburn refractory to proton-pump inhibitors
    Trivedi A.
    Long J.D.
    Current Treatment Options in Gastroenterology, 2007, 10 (1) : 47 - 56
  • [26] Gastroprotection with proton-pump inhibitors in high-risk cardiovascular patients: who to target and for how long?
    Vaduganathan, Muthiah
    Pareek, Manan
    Bhatt, Deepak L.
    EXPERT OPINION ON DRUG SAFETY, 2016, 15 (11) : 1451 - 1453
  • [27] Proton-Pump Inhibitors Are Associated With Increased Cardiovascular Risk Independent of Clopidogrel Use A Nationwide Cohort Study
    Charlot, Mette
    Ahlehoff, Ole
    Norgaard, Mette Lykke
    Jorgensen, Casper H.
    Sorensen, Rikke
    Abildstrom, Steen Z.
    Hansen, Peter Riis
    Madsen, Jan Kyst
    Kober, Lars
    Torp-Pedersen, Christian
    Gislason, Gunnar
    ANNALS OF INTERNAL MEDICINE, 2010, 153 (06) : 378 - 386
  • [28] Proton-pump inhibitors and risk of fractures: an update meta-analysis
    B. Zhou
    Y. Huang
    H. Li
    W. Sun
    J. Liu
    Osteoporosis International, 2016, 27 : 339 - 347
  • [29] Do opioids, sedatives and proton-pump inhibitors increase the risk of fractures?
    Porsdottir, Guolaug
    Benedikz, Elisabet
    Porgeirsdottir, Sigriour A.
    Johannsson, Magnus
    LAEKNABLADID, 2017, 103 (05): : 231 - 235
  • [30] Optimizing cardiovascular and chemopreventive benefits of aspirin: what role for the proton-pump inhibitors?
    Scheiman, J
    ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2005, 21 : 7 - 8
12345